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Introduction
Cluster of Differentiation 64 (CD64) antigen is a mem-
brane glycoprotein expressed on monocytes and macro-
phages. It is the high affinity neutrophil FcgRI receptor
which is weakly expressed by neutrophils at physiological
levels, but strongly upregulated within 4-6 hours by the
pleiotropic cytokines such as Interferon-g (IFN-g) and
Granulocyte Colony Stimulating Factor (G-CSF) which are
produced in sepsis [1]. CD64 can be used as a diagnostic
marker of bacterial infection and sepsis using flow
cytometry.
Objectives
The primary goal of this study was to determine whether
CD64 is a useful biomarker for sepsis in adult critically
ill patients. Secondly, since longitudinal data of CD64
expression are limited in the critically ill patient, a further
goal was to clarify longitudinal expression patterns of
CD64 on neutrophils with regard to outcome and sepsis
severity.
Methods
A prospective observational study between August 2011
and March 2013 in 155 consecutive patients who were
admitted with sepsis, severe sepsis or septic shock was
performed in a mixed medical-surgical ICU in a university
hospital in the Netherlands. CD64 analysis were
performed daily until discharge from ICU or death. Demo-
graphics, clinical, laboratory data and outcome defined as
28-day survival were recorded. They were included within
24 hours from start of antibiotic treatment.
Results
Hundred-and-fifty-five consecutive patients were enrolled.
Patients with a sepsis (1.53; 1.00-2.77) showed a lower
CD64 index than patients with a severe sepsis and septic
shock (2.66 ;1.36-4.49) p = 0.004. Furthermore a peak
value on day two and subsequently a steady decline in all
three groups was seen, independent of outcome.
A significant difference in CD64 at baseline of 2.65
[1.37-4.47] versus 1.74 [0.97-3.16] (p = 0.002) was seen
between patients with a positive culture and negative cul-
ture at admission, respectively. This difference persisted
until two days after inclusion. CD64 index was associated
with severity in organ failure (SOFA-score). The higher
the SOFA score, the higher the CD64 index measured at
the same day. Analysis showed no significant difference
during the first 14 days with regard to CD64 index for
28-day mortality between survivors versus non-survivors,
although, towards the end, non-survivors are showing
higher levels.
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Figure 1 Longitudinal CD64 expression in survivors versus
non-survivors.
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Conclusions
This prospective study demonstrated that CD64 expres-
sion could be of diagnostic support, in addition to current
tests in discriminating between critically ill patients with
culture positive- and negative sepsis. Furthermore, CD64
expression correlates with severity of disease expressed as
the daily SOFA-score, however, CD64 index was not a
good predictor for 28-day mortality in the critically ill
patient.
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Figure 2 Longitudinal CD64 expression in patients with sepsis, SS
and shock.
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